To explore whether SIRT1 was involved in NNMT-related drug resistance, we assessed the change in resistance to ADM or PTX in BC cells after treatment with EX-527 (SIRT1 selective inhibitor) and SIRT1-specific siRNA. Here, SIRT1 is linked to breast cancer.